Company owned by former Steelers QB Batch develops tech for knee injuries
A company established partly by former Steelers quarterback Charlie Batch soon will start making technology developed at the University of Pittsburgh to diagnose and monitor knee injuries, Pitt officials said Thursday.
The company, called Impellia, completed the first of three licenses for technology to prevent injuries and help athletes on the mend, according to a Pitt statement.
The first licensed product is called PIVOT, a software platform developed by researchers at UPMC Sports Medicine. It will help doctors diagnose injuries of the anterior cruciate ligament, or ACL, a tear in one of the knee ligaments.
PIVOT can be used as a diagnostic tool before surgery and during the rehabilitation process to monitor patients, officials said.
“We are thrilled that our PIVOT technology will be made widely available to doctors, physical therapists and athletic trainers,” said Volker Musahl, medical director of the UPMC Rooney Sports Complex and associate professor at the Pitt School of Medicine. “As both a clinician and a researcher, it is gratifying to know that our work will benefit not only elite athletes but also the general population.”
Batch could not be reached for comment.
“Through our team's growth-oriented approach, extensive domain expertise, and sales network, we have the means to build a broad platform for the technology,” he said in a statement.
Impellia plans to announce license agreements for two other products in coming weeks.